Showing results (491-500 of 909) with videos related to
Sort By:
Pageof 91
European Journal of Heart Failure|June 11, 2021
Influence of study discontinuation during the run-in period on the estimated efficacy of sacubitril/valsartan in the PARAGON-HF trialKota Suzuki, Brian Claggett, Masatoshi Minamisawa, et al.The American Journal of Cardiology|March 1, 2008
Usefulness of right ventricular fractional area change to predict death, heart failure, and stroke following myocardial infarction (from the VALIANT ECHO Study)Nagesh S Anavekar, Hicham Skali, Mikhail Bourgoun, et al.Journal of the American College of Cardiology|February 22, 2023
Variation in Renal Function Following Transition to Sacubitril/Valsartan in Patients With Heart FailureSafia Chatur, Brian L Claggett, Finnian R McCausland, et al.European Heart Journal|November 5, 2015
Regional cardiac dysfunction and outcome in patients with left ventricular dysfunction, heart failure, or both after myocardial infarctionNa Wang, Chung-Lieh Hung, Sung-Hee Shin, et al.Family Medicine and Community Health|December 25, 2021
Primary care providers should prescribe aspirin to prevent cardiovascular disease based on benefit-risk ratio, not ageKyungmann Kim, Charles H Hennekens, Lisa Martinez, et al.The American Journal of Cardiology|September 22, 2010
Risk of all-cause mortality, recurrent myocardial infarction, and heart failure hospitalization associated with smoking status following myocardial infarction with left ventricular dysfunctionAmil M Shah, Marc A Pfeffer, L Howard Hartley, et al.Journal of the American College of Cardiology|November 20, 2010
Longitudinal and circumferential strain rate, left ventricular remodeling, and prognosis after myocardial infarctionChung-Lieh Hung, Anil Verma, Hajime Uno, et al.American Heart Journal|August 1, 2006
Metabolic syndrome, C-reactive protein, and prognosis in patients with established coronary artery diseaseDavid Aguilar, Marian R Fisher, Christopher M O'Connor, et al.American Heart Journal|August 10, 2005
Effect of angiotensin-converting enzyme or vasopeptidase inhibition on ventricular size and function in patients with heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE) echocardiographic studyScott D Solomon, Hicham Skali, Mikhail Bourgoun, et al.Circulation. Heart Failure|April 9, 2016
Prognostic Relevance of Left Atrial Dysfunction in Heart Failure With Preserved Ejection FractionAngela B S Santos, Gabriela Querejeta Roca, Brian Claggett, et al.Pageof 91